The total return over the past 12 months is -4.35% vs. +16.94% for the S&P 500. So far it's up +12.64% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (4.35%) | N/A | N/A | N/A | N/A | N/A |
| Total Return CAGR | (4.35%) | N/A | N/A | N/A | N/A | N/A |
| Revenue CAGR | +85.37% | +46.45% | +26.15% | +13.85% | +16.37% | +13.76% |
| Net Income CAGR | N/A | N/A | N/A | +24.96% | +6.09% | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | +4.26% |
| Operating Cash Flow CAGR | N/A | N/A | (8.47%) | +3.80% | +8.18% | +5.33% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Caris Life Sciences, Inc. (CAI)
| Year | Start price | End price | CAI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $26.98 | $30.39 | +12.64% | +14.51% | (1.87%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
